Background. Hyperventilation should speed up elimination of volatile anaesthetic agents from the body, but hyperventilation usually results in hypocapnia. We compared recovery from isourane anaesthesia in patients allowed to recover with assisted spontaneous ventilation (control) and those treated with isocapnic hyperpnoea.
Accepted for publication: July 18, 2003 Hyperventilation increases the rate of elimination of volatile anaesthetics from the blood 1 2 but it also decreases arterial PCO 2 . This can cause post-hyperventilation apnoea, 3 and decrease cerebral blood¯ow, 4 thereby prolonging washout of anaesthetic from the brain. Hyperventilation could facilitate recovery from volatile anaesthetics if the disadvantages of hypocapnia could be prevented. We will refer to increased ventilation without a change in PCO 2 as hyperpnoea'.
Sasano and colleagues 5 demonstrated in dogs that isocapnic hyperpnoea speeded recovery from iso¯urane-maintained anaesthesia. These results may not be applicable clinically if V Ç E cannot be increased mechanically in patients whose airways are controlled with laryngeal masks or tracheal tubes as they recover from anaesthesia. Recovery in humans and dogs may differ because of differences in proportion of muscle and fat, distribution of blood¯ow to the brain, and sensitivity of the brain to anaesthetics. 6 Postsurgical pain, which was absent in the dogs, may also affect arousal. 7 In this study, we compared emergence from anaesthesia with iso¯urane-nitrous oxide in patients who were allowed to recover under assisted spontaneous ventilation (control group) with those who were treated with isocapnic 
Methods
With Institutional Research Board approval and after obtaining written informed consent, 14 ASA class I or II patients undergoing procedures estimated to be 1±2 h in duration were anaesthetized in a standard way. No premedication was used. Induction of anaesthesia was with propofol 2±2.5 mg kg ±1 . The airway was maintained with a laryngeal mask or tracheal tube, according to the preference of the anaesthetist. Tracheal intubation was assisted with fentanyl 1±2 mg kg ±1 and succinylcholine 1±2 mg kg ±1 . Patients breathed spontaneously and anaesthesia was maintained with iso¯urane and nitrous oxide. Fentanyl was given in increments of 25 mg i.v. at the discretion of the anaesthetist, but withheld in the 20 min before the expected completion of surgery. After the application of the wound dressing, patients were randomized to isocapnic hyperpnoea or control groups using sealed envelopes containing equal numbers of papers marked with either`isocapnic hyperpnoea' or`control'.
To begin the recovery period, iso¯urane and nitrous oxide were turned off (time=0). In the control group, patients continued to breathe via the circle anaesthetic circuit. Oxygen¯ow was set greater than 10 litre min ±1 , and the anaesthetist was instructed to assist ventilation as clinically indicated to prevent hypoxia, treat excess hypercarbia, and provide for the elimination of volatile anaesthetics. In the isocapnic hyperpnoea group, the anaesthetic circuit was disconnected from the patient's airway. The patient's lungs were then manually ventilated with the isocapnic hyperpnoea apparatus to maintain end-tidal PCO 2 (PE¢ CO 2 ) at 45± 50 mm Hg independent of V Ç E and without re-breathing. The target ventilation was 15 litre min ±1 measured using the ventilation monitor (Datex AS/3, Helsinki, Finland). The airway was removed (and timing stopped) when patients responded to the command to open their eyes. We monitored vital signs, tidal gas, and vapour concentrations, exhaled minute volume (Datex AS/3, Helsinki, Finland), and the BIS (Aspect Medical Systems, Newton, MA, USA). Data from the AS/3 were digitized at 60 Hz using a DI-720 analogue-to-digital converter (Dataq, Akron, OH, USA) and recorded continuously. Times from turning off the vaporizer to removal of the airway were recorded.
Isocapnic hyperpnoea apparatus
The isocapnic hyperpnoea apparatus ( Fig. 1) was con®gured for the operating room as a modi®ed self-in¯ating bag (Pulmanex, SensorMedics, Yorba Linda, CA, USA) supplied by gases from a compact manifold (SensorMedics) on a stand beside the anaesthetic machine. The manifold was supplied with pure carbon dioxide from an`E-size' cylinder; oxygen was supplied via a T-piece to the manifold from the anaesthetic machine supply. The manifold had a¯owmeter that supplied the self-in¯ating bag with the basal oxygen ow calculated to be equal to that alveolar ventilation resulting in PCO 2 of 50 mm Hg. The manifold also contained a gas blender that blended the pure carbon dioxide and oxygen to provide a mixture of carbon dioxide 6%:oxygen 94% (`reserve gas') and a demand regulator that supplied the reserve gas to the low-pressure relief valve of the selfin¯ating bag. With this system, when V Ç E is equal to or less than the basal oxygen¯ow, the resuscitation bag functions normally, providing oxygen 100%. When however, V Ç E is increased above the oxygen¯ow, the balance of the inspired gas consists of reserve gas drawn through the low-pressure relief valve. The volume of fresh gas entering the alveoli determines the alveolar PCO 2 (PA CO 2 ) and allows the (1) and a low-pressure relief valve (2) with the compact manifold attached. The manifold delivers oxygen 100% from an oxygen source (6) via a¯owmeter, and contains a blender (4), which combines oxygen and carbon dioxide (5) to provide reserve gas to the low-pressure relief valve via a demand regulator (3).
elimination of the volatile anaesthetic. The reserve gas does not affect the PA CO 2 (because its PCO 2 is approximately equal to that in the alveoli), but does increase the gas¯ow allowing washout of the volatile anaesthetic.
Statistical analysis
Analysis was performed using SigmaStat for Windows version 2.0 (Jandel Corporation), on an IBM Thinkpad T23 computer with a Pentium processor and Microsoft WindowsXP operating system. Parametric data were compared using two-tailed t-test with results expressed as means (SD); P-values <0.05 were judged signi®cant. Non-parametric data were analysed using the Mann±Whitney U-test and expressed as medians with inter-quartile values.
Power analysis
We assumed that the average time to emergence in the control group would be about 10 min with an SD of 5 min. Assuming an alpha of 0.05 and a probability of accepting the null hypothesis of 0.8, power analysis predicted a sample size of 13 to identify a reduction of the recovery time by 50%.
Results
Seven patients were assigned to each group (see Table 1 ). Patients in the two groups were comparable with respect to anaesthesia (see Table 2 ). Patients tolerated isocapnic hyperpnoea without gagging, coughing, or cardiovascular instability. The anaesthetist was able to take over the ventilation of most patients; for those who continued to make ventilatory efforts, the anaesthetist assisted the patient's inspiratory efforts, increasing their tidal volume.
Results are shown in Figure 2 . Patients in the isocapnic hyperpnoea and control groups had similar values of PE¢ CO 2 (46.9 (2.7) and 46.8 (3.5) mm Hg, respectively) despite greater V Ç E in the former (17.0 (3.8) vs 5.9 (1.2) litre min ±1 , P<0.05). In the isocapnic hyperpnoea group, time to removal of the airway was less (median and interquartile values of 3.6 (2.7±3.7) vs 12.1 (6.8±17.2) min, P<0.001). BIS scores during emergence for all subjects are shown in Figure 3 . The mean (SD) rate of change of BIS between the end of surgery and removal of the airway was 11.8 (4.4) vs 4.3 (2.7) unit min ±1 (P<0.01) for isocapnic hyperpnoea and control groups, respectively. We did not observe any increase of anaesthetic depth after extubation. Clinical recovery in the post-anaesthetic care unit (PACU), as assessed from the nursing record, was uneventful in both groups. Our assessment was not suf®ciently detailed to detect differences in ®ne motor skills, higher cognitive function, and incidence of post-operative nausea and vomiting. Rapid iso¯urane elimination in humans
Discussion
We describe the ®rst application of isocapnic hyperpnoea to patients to reduce the time of emergence from anaesthesia. In our patients, tripling V Ç E gave a reduced and less variable recovery time. The apparatus described by Sasano and colleagues 5 was convenient to use. It was easy to disconnect the anaesthetic circuit from the patient's airway, turn off the anaesthetic gas¯ow, and attach the self-in¯ating bag to the patient's airway. Stable PE¢ CO 2 values were obtained in all patients regardless of V Ç E without speci®c attention to the pattern of breathing, and without the need for repeated adjustment of oxygen¯ow into the isocapnic hyperpnoea circuit.
The experimental protocol required following a practice that may con¯ict with usual practice. Opioid administration (type and dose) was restricted in the later part of anaesthetic maintenance; the concentrations of nitrous oxide and iso¯urane adjusted accordingly, and maintained without tapering, until the end of surgery. Nevertheless, the protocol provided comparable conditions to test the two strategies for recovery from anaesthesia. Patients were randomized only at the end of surgery so anaesthetists were unable to bias their anaesthetic technique towards either group. In addition, BIS provided an objective measure of recovery.
How much isocapnic hyperpnoea will speed recovery from anaesthesia in practice will depend on the details of the anaesthetic (e.g. agent used, depth and duration of anaesthesia, changes in agent concentration towards the end of surgery, use of adjuvant drugs such as opioids and benzodiazepines, type of airway management), surgery, and patient characteristics (e.g., age, sex, body size, sensitivity to various anaesthetics). Nevertheless, for any given operation and anaesthetic that uses an anaesthetic vapour, there will be a range of recovery times, which could be reduced by increasing the rate of vapour elimination. Isocapnic hyperpnoea may allow this.
To reduce recovery from anaesthesia, much effort and expense has been devoted to developing anaesthetics with low blood solubility, (l). In contrast, we have taken the approach of increasing anaesthetic clearance by increasing V Ç E. The rationale for hyperpnoea to speed emergence from anaesthesia follows from the relation between the factors determining the clearance of volatile anaesthetic agent from the blood passing through the lung as expressed by:
where l is the solubility of the vapour in blood, Q Ç is cardiac output, and V Ç E is alveolar ventilation.
1 Figure 4 illustrates that with only an approximately 3.5-fold increase in V Ç E, the clearance of iso¯urane (l=1.38) 8 becomes equal to that of des¯urane (l=0.42). 8 Times to removal of the airway in our control subjects were within those reported previously for iso¯urane but those in our subjects treated with isocapnic hyperpnoea were within the 4±10 min range expected for des¯urane and sevo¯urane (see tables VI and VII in Patel and Goa 8 ). The ef®cacy of hyperpnoea in accelerating recovery from anaesthesia is not surprising. 9 In 1923, White 10 reported that the average time for recovery of consciousness from ether anaesthesia could be reduced from an average of 75 to 14 min by adding carbon dioxide to inhaled gas, thereby increasing V Ç E to 25±35 litre min ±1 . The use of hyperpnoea and adding carbon dioxide to inspired gas continued to be popular. A random survey of 1528 anaesthetists in the UK published in 1989 indicated that 60% of the 1100 respondents routinely used carbon dioxide. 11 Since that time, the practice has been discouraged (Checklist For Anaesthetic Apparatus, 2, Association of Anaesthetists, 1997). In North America, adding carbon dioxide to the inspiratory limb of a circuit to stimulate breathing or to maintain isocapnia during imposed hyperpnoea is now seldom practised, mainly because it is technically awkward to perform, risks inadvertent hypercarbia, 12 and increases the consumption of carbon dioxide absorbent.
Sasano and colleagues 5 recently introduced a new method of non re-breathing isocapnic hyperpnoea, which avoids the risk of hypercarbia. Manual hyperventilation is applied using a separate circuit consisting of a modi®ed standard self-in¯ating bag (Fig. 1) . Patients can be monitored routinely with pulse oximeter and capnograph. The isocapnic hyperpnoea circuit provides oxygen at low V Ç E and, when V Ç E is increased, adds carbon dioxide in the form of carbon dioxide 6% in oxygen, in direct proportion to the increase in V Ç E in order to maintain isocapnia. 13 The separate circuit, in contrast to using carbogen (carbon dioxide 5%, oxygen 95%), maintains isocapnia independent of V Ç E without increasing the rate of consumption of the carbon dioxide absorbent.
The isocapnic hyperpnoea circuit has an additional failsafe feature. Even with only mild hyperpnoea (10 litre min ±1 ) and with a complete failure of oxygen¯ow (oxygen ow=0), in a 70 kg male, the Pa CO 2 would equilibrate between 70 and 80 mm Hg, which is unlikely to be dangerous in most well-oxygenated patients. Moreover, hyperpnoea with reserve gas alone will still result in the patient waking within the same time as with the oxygen¯ow and therefore the PE¢ CO 2 might not have time to reach that equilibrium value.
Increased V Ç E affects the rate of elimination of iso¯urane from the lungs. 2 As the equilibration of iso¯urane in the blood with the tissues is very rapid, 14 the removal of iso¯urane from the blood via the lungs will be followed closely by removal from the vessel rich group (VRG). The Rapid iso¯urane elimination in humans clearance of anaesthetic from the various parts of the VRG will also depend on their respective blood¯ows. Conventional hyperventilation and reduction of Pa CO 2 at the end of surgery reduces blood¯ow to the brain, and may delay the clearance of anaesthetic from the brain relative to other tissues of the VRG. This would offset the effect of more rapid elimination from the blood on time to recovery. For an equivalent minute ventilation, maintaining normocapnia and higher brain blood¯ow should allow more rapid equilibration of partial pressures of anaesthetic between brain and arterial blood. However, further investigation is required to ascertain whether isocapnic hyperpnoea shortens or improves the quality of emergence compared with hyperventilation. A further consideration is the effect of hyperpnoea on cardiovascular stability. Henderson and Haggard 9 increased V Ç E to 30±70 litre min ±1 in their ether-anaesthetized patients and noted a decrease in arterial pressure of only 5±15 mm Hg. Deliberate hyperpnoea does not decrease stroke volume or arterial pressure in animals 15 16 or humans. 17 We observed no cardiovascular effects of increased V Ç E with isocapnic hyperpnoea to, at most, 20 litre min ±1 . However, the isocapnic hyperpnoea was applied during recovery when arterial pressure and heart rate naturally increase and this may have obscured any such effects.
Isocapnic hyperpnoea may also speed up the elimination from the blood, via the lung, of other volatile agents such as carbon monoxide 18 19 and be useful as a research tool in studying the pharmacokinetics of such agents, or in other instances in which it is necessary to keep the patient's PCO 2 constant.
Conclusion
Isocapnic hyperpnoea was successfully applied in the operating room and, for our anaesthetic protocol, resulted in faster, less variable emergence time.
